Atlas Trials

Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer

Clinical trial NCT04256616 · UNKNOWN

Trial details

NCT number
NCT04256616
Sponsor
Istituto Clinico Humanitas
Status
UNKNOWN
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2018-06-27
Primary completion
2020-09-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.